Cargando…

An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells

Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yifang, Wang, Daqi, Lan, Feng, Wei, Gang, Ni, Ting, Chai, Renjie, Liu, Dong, Hu, Shijun, Li, Mingqing, Li, Dajin, Wang, Hongyan, Wang, Yongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443789/
https://www.ncbi.nlm.nih.gov/pubmed/28539611
http://dx.doi.org/10.1038/s41598-017-02456-y
_version_ 1783238619060764672
author Xie, Yifang
Wang, Daqi
Lan, Feng
Wei, Gang
Ni, Ting
Chai, Renjie
Liu, Dong
Hu, Shijun
Li, Mingqing
Li, Dajin
Wang, Hongyan
Wang, Yongming
author_facet Xie, Yifang
Wang, Daqi
Lan, Feng
Wei, Gang
Ni, Ting
Chai, Renjie
Liu, Dong
Hu, Shijun
Li, Mingqing
Li, Dajin
Wang, Hongyan
Wang, Yongming
author_sort Xie, Yifang
collection PubMed
description Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-based CRISPR/Cas9 system, which we called epiCRISPR, for highly efficient gene knockout in hPSCs. The epiCRISPR system enables generation of up to 100% Insertion/Deletion (indel) rates. In addition, the epiCRISPR system enables efficient double-gene knockout and genomic deletion. To minimize off-target cleavage, we combined the episomal vector technology with double-nicking strategy and recent developed high fidelity Cas9. Thus the epiCRISPR system offers a highly efficient platform for genetic analysis in hPSCs.
format Online
Article
Text
id pubmed-5443789
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54437892017-05-26 An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells Xie, Yifang Wang, Daqi Lan, Feng Wei, Gang Ni, Ting Chai, Renjie Liu, Dong Hu, Shijun Li, Mingqing Li, Dajin Wang, Hongyan Wang, Yongming Sci Rep Article Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-based CRISPR/Cas9 system, which we called epiCRISPR, for highly efficient gene knockout in hPSCs. The epiCRISPR system enables generation of up to 100% Insertion/Deletion (indel) rates. In addition, the epiCRISPR system enables efficient double-gene knockout and genomic deletion. To minimize off-target cleavage, we combined the episomal vector technology with double-nicking strategy and recent developed high fidelity Cas9. Thus the epiCRISPR system offers a highly efficient platform for genetic analysis in hPSCs. Nature Publishing Group UK 2017-05-24 /pmc/articles/PMC5443789/ /pubmed/28539611 http://dx.doi.org/10.1038/s41598-017-02456-y Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Xie, Yifang
Wang, Daqi
Lan, Feng
Wei, Gang
Ni, Ting
Chai, Renjie
Liu, Dong
Hu, Shijun
Li, Mingqing
Li, Dajin
Wang, Hongyan
Wang, Yongming
An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
title An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
title_full An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
title_fullStr An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
title_full_unstemmed An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
title_short An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
title_sort episomal vector-based crispr/cas9 system for highly efficient gene knockout in human pluripotent stem cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443789/
https://www.ncbi.nlm.nih.gov/pubmed/28539611
http://dx.doi.org/10.1038/s41598-017-02456-y
work_keys_str_mv AT xieyifang anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT wangdaqi anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT lanfeng anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT weigang anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT niting anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT chairenjie anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT liudong anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT hushijun anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT limingqing anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT lidajin anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT wanghongyan anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT wangyongming anepisomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT xieyifang episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT wangdaqi episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT lanfeng episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT weigang episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT niting episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT chairenjie episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT liudong episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT hushijun episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT limingqing episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT lidajin episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT wanghongyan episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells
AT wangyongming episomalvectorbasedcrisprcas9systemforhighlyefficientgeneknockoutinhumanpluripotentstemcells